Following the publication of the final paper in a planned series of four studies estimating the economic returns from biomedical and health research, we reflect on what we have learnt from these types of assessment.
- health economics
- science policy
- musculoskeletal disease
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Contributors The paper was conceived by JG and MJB who made an equal contribiton to the paper, critically reviewing various iterations and approving the final draft submitted.
Funding This paper was not supported by direct funding. The studies synthesised in the paper were funded through a series of research grant from the Wellcome Trust, Arthritis Research UK, the Medical Research Council (MRC), National Institutes for Health Research (NIHR), Academy of Medical Sciences and Cancer Research UK.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The synthesised data used and generated during this study are included in the cited papers and additional files.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.